Giuseppe Plazzi

Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trial

Yves Dauvilliers, Michel Lecendreux, Gert Jan Lammers et al. · The Lancet Neurology · 2023 · 109 citations · Full text

Pharmacy, Pediatrics, Pharmacology +11

Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning

Zhongxing Zhang, Geert Mayer, Yves Dauvilliers et al. · Scientific Reports · 2018 · 60 citations · Full text

Computing, Computer Science, Neurology +15

Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1

Yves Dauvilliers, Giuseppe Plazzi, Emmanuel Mignot et al. · New England Journal of Medicine · 2025 · 33 citations

Medicine, Pharmacology, Pharmacotherapy +17

New 2013 incidence peak in childhood narcolepsy: more than vaccination?

Zhongxing Zhang, Jari K. Gool, Rolf Fronczek et al. · SLEEP · 2020 · 22 citations · Full text

Public Health, Child Health, Infectious Diseases +7

Combining information on nocturnal rapid eye movement sleep latency and atonia to facilitate diagnosis of pediatric narcolepsy type 1

Alessandro Silvani, Stefano Vandi, Fabio Pizza et al. · SLEEP · 2020 · 21 citations · Full text

Medicine, Neurology, Pediatrics +15